Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.
about
Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathwayRegulation of transforming growth factor alpha expression in a growth factor-independent cell lineApoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulinClinical impact of novel treatment strategies.The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.Potential use of humanized antibodies in the treatment of breast cancer.Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.Implications of EGFR PharmDx kit for cetuximab eligibility.The EGF receptor system as a target for antitumor therapy.Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element.Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function.Dietary fatty acids and breast cancer invasion and metastasis.Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis.Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.A 34-kd protein with strong homology to ras-like proteins inhibits epidermal growth factor activity.Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity.Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptorLoss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis.Epidermal growth factor in NMU-induced mammary tumors in rats.Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro.Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector
P2860
Q24649739-2B11DDEE-5DCA-481C-B66D-853C11960746Q33996729-22F50645-B79B-4AA9-9F94-21D008B92826Q34212131-8A2F51D4-0588-4803-AF07-41F1FF872320Q34936052-421C3930-70B9-4C3E-A395-14495132AF41Q35975667-7BD6C761-5233-4FA9-A53B-B0B857A79EBEQ36236062-5692AAFE-6C43-4899-BEB5-B1FCEC51F93FQ36532110-44C549AD-B00E-4D92-8ACC-3DECCBC55C36Q36617757-D6B7C928-EC84-49BD-9381-66468E0B398AQ36893092-FDB7FFFF-E217-4F78-B902-8E58A2199FE5Q37118974-CE983C8B-BD9E-433F-BA54-66B8CEB39032Q37427689-2CBD2450-877B-4264-8AD3-526BE2C56788Q38314973-DEABE7B8-CAD7-4B85-8B46-43E528A4AFF4Q38318597-50274D2E-CBDD-4DF7-9A77-397E5429C5B5Q38328123-901FC40B-4385-4648-8F05-CC0A2019C4EFQ38346921-93C85CA7-3256-4B32-A809-6EB2AD859F65Q40687863-EE40D8A2-AC1D-417C-9AD6-C75DA068E484Q40923662-E6BE03A6-0D6F-4F7B-8186-AAD31C779823Q40952877-DEE4BB60-AAE2-46CE-B13E-079B7324D573Q41326011-4BA97813-9235-4ABE-BDE6-5066D0E8ACDBQ41561510-E32FE424-3BC8-498F-990B-27D587BB9B3EQ41887619-DD8A6D9F-36C4-44B3-B416-2AA5A305BC03Q41911341-57EE4A87-9A57-4C19-BBB1-6F11A0ED4B8EQ42441080-E6B98076-A50A-45BA-AB44-56006AFD91D7Q42498384-063BAD5F-9712-40ED-89E7-3D68F36054E8Q53457015-650A1E7E-24C1-4CA7-81C1-920FC102B1F5Q54647645-DA432646-7D7A-4247-92C4-135DED2169B2Q54967617-0128B653-16D2-4F98-A0BE-DB5E84D9C480Q57424704-D4040468-B294-4CB9-BF4F-0AD714E8BA89
P2860
Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@en
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@nl
type
label
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@en
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@nl
prefLabel
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@en
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@nl
P2093
P356
P1476
Anti-epidermal growth factor r ...... 468 human breast cancer cells.
@en
P2093
Goldenberg A
Lippman ME
Mendelsohn J
Schlessinger J
Valverius EM
P304
P356
10.1210/MEND-3-11-1830
P577
1989-11-01T00:00:00Z